Venus Remedies has been awarded the company registration from Gulf Cooperation Council
Panchkula-based Venus Remedies Ltd, an existing Eu-GMP certified Pharmaceutical manufacturing company, has been awarded the company registration from GCC (Gulf Cooperation Council). This approval holds significance as such registrations are obtained by the manufacturing facilities which meet world class standards and where quality is of the prime essence.
On the occasion, chairman cum managing director of Venus Remedies Pawan Chaudhary said, "With this prestigious grant Venus Remedies will strengthen its footmark in GCC pharmaceutical market and will enhance its revenues by 10% by 2013."
Venus Remedies is already present in different countries of Middle East with its products in oncology, carbapenem/cephalosprin segment. With this company registration certificate, Venus Remedies now features as the first Indian company having received the GCC approval to market its Oncology & Carbapenem range of products in all the GCC countries comprising of Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman.
Earlier, Venus was also awarded Saudi Arabia FDA GMP which gave it the opportunity to enter the Saudi Arabian market worth of $ 3.5 billion.
On Thursday, Venus Remedies ended 1.92% down at Rs214.65 on the Bombay Stock Exchange, while the benchmark Sensex declined 1.14% to 18,149.87.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
